JosephASparanoMD

Clinical Trials

• Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy Start of enrollment: 1997 Dec 02

  Completed

  Phase 3

• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes Start of enrollment: 1999 Nov 16

  Completed

  Phase 3

• Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma Start of enrollment: 2003 Mar 01

  Completed

  Phase 2

• Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer Start of enrollment: 2003 Feb 01

  Completed

  Phase 2

• Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer Start of enrollment: 2004 May 01

  Completed

  Phase 2

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07

  Active, not recruiting

  Phase 3

• Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Start of enrollment: 2007 Feb 28

  Completed

  Phase 2

• Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer Start of enrollment: 2006 Sep 01

  Completed

  Phase 2

• Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer Start of enrollment: 2006 Jul 01

  Completed

  Phase 1, Phase 2

• Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer Start of enrollment: 2007 Apr 01

  Completed

  Phase 1, Phase 2

• Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy Start of enrollment: 2007 Dec 01

  Completed

  Phase 1, Phase 2

• Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy Start of enrollment: 2005 Oct 07

  Completed

• Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer Start of enrollment: 2010 May 26

  Completed

  Phase 2

• Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer Start of enrollment: 2010 Jun 01

  Completed

  Phase 1

• Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer Start of enrollment: 2010 Jun 30

  Active, not recruiting

  Phase 2

• Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Start of enrollment: 2010 Oct 06

  Completed

  Phase 1, Phase 2

• Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer Start of enrollment: 2010 Nov 16

  Completed

  Phase 1

• MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Start of enrollment: 2011 Apr 01

  Terminated

  Phase 2

• Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer Start of enrollment: 2011 Apr 21

  Active, not recruiting

  Phase 2

• Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 May 02

  Active, not recruiting

  Phase 1

• A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01

  Terminated

  Phase 2

• Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma Start of enrollment: 2012 Aug 31

  Active, not recruiting

  Phase 1

• PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer Start of enrollment: 2012 Jan 01

  Terminated

  Phase 1, Phase 2

• Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer Start of enrollment: 2013 Feb 01

  Terminated

  Phase 2

• Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer Start of enrollment: 2013 Jun 01

  Active, not recruiting

  Not Applicable

• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17

  Completed

  Phase 3

• Endocrine Response in Women With Invasive Lobular Breast Cancer Start of enrollment: 2015 Sep 30

  Active, not recruiting

  Phase 2

  Roles: Contact

• Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer Start of enrollment: 2016 Mar 01

  Active, not recruiting

  Phase 2

• TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer Start of enrollment: 2018 Dec 12

  Recruiting

  Not Applicable

• Join now to see all